Capital Wealth Alliance LLC Takes Position in UnitedHealth Group Incorporated $UNH

Capital Wealth Alliance LLC purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 882 shares of the healthcare conglomerate’s stock, valued at approximately $275,000.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Granite Harbor Advisors Inc. increased its stake in UnitedHealth Group by 36.3% in the 2nd quarter. Granite Harbor Advisors Inc. now owns 1,775 shares of the healthcare conglomerate’s stock worth $554,000 after purchasing an additional 473 shares during the period. RNC Capital Management LLC grew its holdings in UnitedHealth Group by 20.3% in the 2nd quarter. RNC Capital Management LLC now owns 21,685 shares of the healthcare conglomerate’s stock worth $6,765,000 after acquiring an additional 3,659 shares during the last quarter. Greatmark Investment Partners Inc. boosted its holdings in shares of UnitedHealth Group by 10.2% during the second quarter. Greatmark Investment Partners Inc. now owns 810 shares of the healthcare conglomerate’s stock worth $253,000 after purchasing an additional 75 shares during the period. Caliber Wealth Management LLC KS increased its stake in shares of UnitedHealth Group by 43.6% during the second quarter. Caliber Wealth Management LLC KS now owns 10,360 shares of the healthcare conglomerate’s stock valued at $3,232,000 after buying an additional 3,148 shares during the period. Finally, BlueChip Wealth Advisors LLC raised its holdings in UnitedHealth Group by 10.0% in the 2nd quarter. BlueChip Wealth Advisors LLC now owns 891 shares of the healthcare conglomerate’s stock worth $278,000 after purchasing an additional 81 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Down 1.1%

Shares of UnitedHealth Group stock opened at $361.29 on Thursday. The company’s 50 day moving average is $335.48 and its 200 day moving average is $341.42. The company has a market cap of $327.21 billion, a price-to-earnings ratio of 15.65, a price-to-earnings-growth ratio of 2.36 and a beta of 0.47. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is 38.30%.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on UNH. Cantor Fitzgerald reissued an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Weiss Ratings reissued a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Wednesday, October 8th. Barclays boosted their price objective on shares of UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. Piper Sandler cut their target price on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. Finally, JPMorgan Chase & Co. upped their price target on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. Eighteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $385.13.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.